Literature DB >> 32291702

Randomized Controlled Trial Comparing the Outcomes of Enhanced Recovery After Surgery and Standard Recovery Pathways in Laparoscopic Sleeve Gastrectomy.

S Prabhakaran1, Shivanshu Misra1, M Magila1, S Saravana Kumar1, Sudarsan Kasthuri1, Chinnusamy Palanivelu1, P Praveen Raj2.   

Abstract

PURPOSE: The enhanced recovery after surgery (ERAS) pathway is an evidence-based perioperative pathway that results in less pain, earlier recovery, and lower complication rates. Studies to prove their efficacy over standard recovery pathways in the Indian population are scarce. Our study intends to compare the outcomes of these pathways in the Indian community focusing on hospital stay, postoperative pain, and time for rescue analgesia.
MATERIALS AND METHODS: This is a single-blinded RCT involving 112 patients who underwent laparoscopic sleeve gastrectomy (LSG). The groups were divided into ERAS and standard pathway arms by closed envelope technique. The primary outcome was the length of hospital stay, while the secondary outcomes included pain score; postoperative nausea, and vomiting (PONV); time for rescue analgesia; and ambulation.
RESULTS: Of 112 patients included, 56 were allocated in the ERAS group, and the remaining 56 were included in the standard pathway group. We found no significant differences in the baseline characteristics between the two groups. Mean hospital stay was significantly lower in the ERAS group compared to the standard group (p = 0.003). In comparison to the standard group, ERAS patients were ambulated early, and the difference was highly significant (p < 0.001). Pain scores between the two groups showed a significant difference during the 4th hour and 8th hour. We also found a significant variation between the time for first rescue analgesia and the two groups (p < 0.001).
CONCLUSION: Patients who followed ERAS protocol were found to have shortened hospital stay, decreased pain, early ambulation, and reduced need for rescue analgesia. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03191318.

Entities:  

Keywords:  ERAS; LSG; RCT; Standard pathway

Mesh:

Year:  2020        PMID: 32291702     DOI: 10.1007/s11695-020-04585-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  3 in total

Review 1.  Central nervous respiratory depressants--narcotic analgesics.

Authors:  H L Borison
Journal:  Pharmacol Ther B       Date:  1977

2.  Results of Implementing an Enhanced Recovery After Bariatric Surgery (ERABS) Protocol.

Authors:  Guido H H Mannaerts; Stefanie R van Mil; Pieter S Stepaniak; Martin Dunkelgrün; Marcel de Quelerij; Serge J Verbrugge; Hans F Zengerink; L Ulas Biter
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

3.  The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting.

Authors:  J J Wang; S T Ho; J I Tzeng; C S Tang
Journal:  Anesth Analg       Date:  2000-07       Impact factor: 5.108

  3 in total
  3 in total

Review 1.  Enhanced recovery after bariatric surgery: an Italian consensus statement.

Authors:  Giuseppe Marinari; Mirto Foletto; Carlo Nagliati; Giuseppe Navarra; Vincenzo Borrelli; Vincenzo Bruni; Giovanni Fantola; Roberto Moroni; Luigi Tritapepe; Roberta Monzani; Daniela Sanna; Michele Carron; Rita Cataldo
Journal:  Surg Endosc       Date:  2022-08-11       Impact factor: 3.453

2.  Pre-incisional Laparoscopic Preperitoneal Local Anesthetic Technique in Laparoscopic Sleeve Gastrectomy.

Authors:  Abdullah Aldohayan; Sulaiman Alshammari; Ahmed Binjaloud; Fahad Bamehriz; Abdul Sattar Narejo; Mansoor Aqil; Nahlah Aldahian; Abdulaziz Aldabaeab; Abdelazeem Eldawlatly
Journal:  JSLS       Date:  2022 Jul-Sep       Impact factor: 1.789

3.  Transcutaneous electrical acupoint stimulation combined with electroacupuncture for rapid recovery of patients after laparotomy for gastrointestinal surgery: a study protocol for a randomised controlled trial.

Authors:  Hao Li; Qian Wen; Lingyun Lu; Hangqi Hu; Ying He; Yaming Zhou; Xiaoting Wu; Ning Li
Journal:  BMJ Open       Date:  2021-11-02       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.